BioCorRx Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioCorRx Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • BioCorRx Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $11.2M, a 8.62% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $11.2M +$891K +8.62% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $10.3M +$973K +10.4% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $9.36M +$2.71M +40.7% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $6.65M +$12.3M Dec 31, 2020 10-K 2022-03-31
Q4 2019 -$5.68M -$1.69M -42.4% Dec 31, 2019 10-K 2021-03-31
Q4 2018 -$3.99M -$7.08M -229% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $3.1M +$1.15M +59.2% Dec 31, 2017 10-K 2019-04-16
Q4 2016 $1.95M -$20.6K -1.05% Dec 31, 2016 10-K 2018-04-05
Q4 2015 $1.97M -$555K -22% Dec 31, 2015 10-K 2017-04-13
Q4 2014 $2.52M +$4.29M Dec 31, 2014 10-K 2016-04-14
Q4 2013 -$1.77M -$1.1M -166% Dec 31, 2013 10-K 2015-03-31
Q4 2012 -$664K Dec 31, 2012 10-K 2014-04-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.